112 related articles for article (PubMed ID: 33835973)
1. Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance.
Fujiwara Y; Tsunedomi R; Yoshimura K; Matsukuma S; Fujiwara N; Nishiyama M; Kanekiyo S; Matsui H; Shindo Y; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Pancreas; 2021 Mar; 50(3):405-413. PubMed ID: 33835973
[TBL] [Abstract][Full Text] [Related]
2. Calreticulin is highly expressed in pancreatic cancer stem-like cells.
Matsukuma S; Yoshimura K; Ueno T; Oga A; Inoue M; Watanabe Y; Kuramasu A; Fuse M; Tsunedomi R; Nagaoka S; Eguchi H; Matsui H; Shindo Y; Maeda N; Tokuhisa Y; Kawano R; Furuya-Kondo T; Itoh H; Yoshino S; Hazama S; Oka M; Nagano H
Cancer Sci; 2016 Nov; 107(11):1599-1609. PubMed ID: 27561105
[TBL] [Abstract][Full Text] [Related]
3. Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.
Huang P; Wang CY; Gou SM; Wu HS; Liu T; Xiong JX
World J Gastroenterol; 2008 Jun; 14(24):3903-7. PubMed ID: 18609717
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Notch2(+) pancreatic cancer stem-like cells and the relationship with centroacinar cells.
Zhou ZC; Dong QG; Fu DL; Gong YY; Ni QX
Cell Biol Int; 2013 Aug; 37(8):805-11. PubMed ID: 23536545
[TBL] [Abstract][Full Text] [Related]
7. Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.
Okada M; Shibuya K; Sato A; Seino S; Suzuki S; Seino M; Kitanaka C
Oncotarget; 2014 Jul; 5(13):5100-12. PubMed ID: 24947996
[TBL] [Abstract][Full Text] [Related]
8. 5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1.
Zhao J; Shi X; Dong C; Liu R; Su L; Cao C
Folia Histochem Cytobiol; 2022; 60(1):55-65. PubMed ID: 35103981
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells loaded with pancreatic Cancer Stem Cells (CSCs) lysates induce antitumor immune killing effect in vitro.
Yin T; Shi P; Gou S; Shen Q; Wang C
PLoS One; 2014; 9(12):e114581. PubMed ID: 25521461
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
Wang L; Zhang Y; Wang W; Zhu Y; Chen Y; Tian B
PLoS One; 2017; 12(8):e0184110. PubMed ID: 28854261
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Profiling of Panc-1 Spheroid Cells with Pancreatic Cancer Stem Cells Properties Cultured by a Novel 3D Semi-Solid System.
Yang Z; Zhang Y; Tang T; Zhu Q; Shi W; Yin X; Xing Y; Shen Y; Pan Y; Jin L
Cell Physiol Biochem; 2018; 47(5):2109-2125. PubMed ID: 29975934
[TBL] [Abstract][Full Text] [Related]
12. Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties.
Gou S; Liu T; Wang C; Yin T; Li K; Yang M; Zhou J
Pancreas; 2007 May; 34(4):429-35. PubMed ID: 17446842
[TBL] [Abstract][Full Text] [Related]
13. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
[TBL] [Abstract][Full Text] [Related]
14. [Phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway is critical for survival and proliferation of pancreatic cancer stem-like side population cells].
Zhou J; Wang CY; Liu T; Wu HS; Zhou F; Xiong JX; Zhao G; Yang M; Yin T; Zhou MT
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2994-8. PubMed ID: 19080079
[TBL] [Abstract][Full Text] [Related]
15. Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells.
Kimura Y; Tsunedomi R; Yoshimura K; Matsukuma S; Shindo Y; Matsui H; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Ann Surg Oncol; 2022 Nov; 29(12):7423-7433. PubMed ID: 35876924
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
[TBL] [Abstract][Full Text] [Related]
17. An epithelial cell adhesion molecule- and CD3-bispecific antibody plus activated T-cells can eradicate chemoresistant cancer stem-like pancreatic carcinoma cells in vitro.
Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M; Morisaki T
Anticancer Res; 2014 Aug; 34(8):4509-19. PubMed ID: 25075094
[TBL] [Abstract][Full Text] [Related]
18. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
19. Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers.
Al-Assar O; Muschel RJ; Mantoni TS; McKenna WG; Brunner TB
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1216-25. PubMed ID: 19857785
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells.
Tsunedomi R; Yoshimura K; Kimura Y; Nishiyama M; Fujiwara N; Matsukuma S; Kanekiyo S; Matsui H; Shindo Y; Watanabe Y; Tokumitsu Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
BMC Cancer; 2022 Mar; 22(1):260. PubMed ID: 35277124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
